Alpha Cognition Inc. - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ACOG Nasdaq 2830 www.alphacognition.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Alpha Cognition Inc.

What Makes Alpha Cognition Inc. (ACOG) a New Strong Buy Stock - Jul 4th, 2025 10:00 am
Alpha Cognition Announces Positive Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury - Jul 1st, 2025 3:05 pm
Is Alpha Cognition Inc. (ACOG) Outperforming Other Medical Stocks This Year? - Jul 1st, 2025 7:40 am
Should You Buy Alpha Cognition Inc. (ACOG) After Golden Cross? - Jun 16th, 2025 7:55 am
Alpha Cognition Inc. Common Stock (ACOG): A Bull Case Theory - Jun 6th, 2025 2:31 pm
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q1 2025 - May 19th, 2025 8:25 am
We Think Alpha Cognition (NASDAQ:ACOG) Can Easily Afford To Drive Business Growth - May 17th, 2025 6:21 am
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates - May 15th, 2025 3:40 pm
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview - May 15th, 2025 6:30 am
Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview - May 1st, 2025 6:30 am
Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - Apr 30th, 2025 5:30 am
Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer’s Association International Conference - Apr 28th, 2025 6:30 am
Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens - Apr 10th, 2025 6:30 am
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024 - Apr 1st, 2025 2:27 pm
Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview - Mar 31st, 2025 6:30 am
Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview - Mar 19th, 2025 2:30 pm
Alpha Cognition Announces the Commercial Launch of ZUNVEYL (Benzgalantamine) for the Treatment of Mild to Moderate Alzheimer’s Disease - Mar 18th, 2025 6:30 am
Alpha Cognition Inc. (NASDAQ:ACOG) surges 13%; retail investors who own 46% shares profited along with institutions - Feb 20th, 2025 6:11 am
Alpha Cognition Secures Additional U.S. Patent for ZUNVEYL (benzgalantamine) in the Treatment of Mild to Moderate Alzheimer’s disease - Feb 12th, 2025 6:30 am
Stonegate Capital Partners Initiates Coverage on Alpha Cognition Inc. (ACOG) - Jan 30th, 2025 9:05 am